RAD51B and age-related macular degeneration: Seddon et al. conducted a 12-year follow-up study of 2765 individuals and revealed that RAD51B (HR: 0.8; 95% CI: 0.60-0.97, p = 0.03) was significantly related to AMD progression [26].